Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Childhood-onset schizophrenia is a rare but severe form of the disorder that is often treatment-refractory. In this study, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia. METHODS: Twenty-one patients (mean [+/-SD] age, 14.0 +/- 2.3 years) with onset of Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition-defined schizophrenia that began by age 12 years and who had been nonresponsive to typical neuroleptics participated in the study. Patients were randomized to a 6-week double-blind parallel comparison of clozapine (mean [+/-SD] final dose, 176 +/- 149 mg/d), or haloperidol, (16 +/- 8 mg/d). RESULTS: Clozapine was superior to haloperidol on all measures of psychosis (P = .04-.002). Positive and negative symptoms of schizophrenia improved. However, neutropenia and seizures were major concerns. To date, one third of the group has discontinued using clozapine. CONCLUSIONS: Clozapine has striking superiority for positive and negative symptoms in treatment-refractory childhood-onset schizophrenia. However, due to possibly increased toxic effects in this pediatric population, close monitoring for adverse events is essential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These medications remain of major importance, including clozapine, the most effective (and toxic) of all for childhood psychosis (46,47).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [46]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
Benes, F. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060041004 · Cited by 744
Breier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
BUNNEY, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.20 · Cited by 388
Pickar, D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050009001 · Cited by 354
Cited by
Items 101–200 of 412
Dong, S., Schneider-Thoma, J., Bighelli, I., Siafis, S., Wang, D., Burschinski, A., Schestag, K., Samara, M., & Leucht, S. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01654-2 · Cited by 68
Hematological Adverse Events in Clozapine-Treated Children and Adolescents
Gerbino-Rosen, G., Roofeh, D., Tompkins, D. A., Feryo, D., Nusser, L., Kranzler, H. N., Napolitano, B. A., Frederickson, A. M., Henderson, I., Rhinewine, J., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000171904.23947.54 · Cited by 68
Self-citationClozapine use in children and adolescents
Gogtay, N., & Rapoport, J. L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.3.459 · Cited by 75
The side effect profile of Clozapine in real world data of three large mental health hospitals
Iqbal, E., Govind, R., Romero, A., Dzahini, O., Broadbent, M. T. M., Stewart, R. J., Smith, T. D., Kim, C.-H., Werbeloff, N., MacCabe, J. H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243437 · Cited by 68
Mattai, A. A., Weisinger, B., Greenstein, D., Stidd, R., Clasen, L., Miller, R., Tossell, J. W., Rapoport, J. L., & Gogtay, N. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.03.016 · Cited by 61
Psychosis in Children and Adolescents
McClellan, J. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.01.021 · Cited by 76
Psychotic Disorders in Children and Adolescents: A Primer on Contemporary Evaluation and Management
Stevens, J. R., Prince, J. B., Prager, L. M., & Stern, T. A. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13f01514 · Cited by 73
Community-Based Interventions in a System of Care and Outcomes Framework
Duchnowski, A. J., Kutash, K., & Friedman, R. M. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0002 · Cited by 69
Doey, T., Handelman, K., Seabrook, J. A., & Steele, M. M. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200605 · Cited by 62
Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz‐Dahlmann, B., Holtkamp, K., Mehler‐Wex, C., Rauh, R., Remschmidt, H., Schulz, E., & Warnke, A. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0105-9 · Cited by 62
Mozes, T., Ebert, T., Michal, S.-E., Spivak, B., & Weizman, A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.393 · Cited by 66
Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
Gothelf, D., Apter, A. S., REIDMAN, J., Brand‐Gothelf, A., Bloch, Y., Gal, G., Kikinzon, L., Tyano, S., Weizman, R., & RATZONI, G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0803-7 · Cited by 62
IQ stabilization in childhood-onset schizophrenia
Gochman, P., GREENSTEIN, D. K., Sporn, A. L., Gogtay, N., Keller, B., Shaw, P., & Rapoport, J. L. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.002 · Cited by 68
A Prospective, Open-Label Trial of Olanzapine in Adolescents With Schizophrenia
FINDLING, R. L., MCNAMARA, N. K., YOUNGSTROM, E. A., BRANICKY, L. A., DEMETER, C. A., & SCHULZ, S. C. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200302000-00010 · Cited by 62
Dynamic mapping of hippocampal development in childhood onset schizophrenia
NUGENTIII, T., Herman, D. H., Ordóñez, A. E., GREENSTEIN, D., HAYASHI, K., Lenane, M., CLASEN, L. S., JUNG, D., Toga, A. W., & Giedd, J. N. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.10.014 · Cited by 66
Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents
Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz‐Dahlmann, B., Holtkamp, K., Mehler‐Wex, C., Rauh, R., Remschmidt, H., Schulz, E., & Warnke, A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0602-7 · Cited by 59
Clinical Drug Monitoring in Child and Adolescent Psychiatry: Side Effects of Atypical Neuroleptics
Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz‐Dahlmann, B., Holtkamp, K., Mehler‐Wex, C., Rauh, R., Remschmidt, H., Schulz, E., & Warnke, A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.308 · Cited by 59
Clozapine: Its Impact on Aggressive Behavior Among Children and Adolescents With Schizophrenia
Kranzler, H. N., Roofeh, D., Gerbino-Rosen, G., Dombrowski, C., McMeniman, M., DeThomas, C., Frederickson, A. M., Nusser, L., BIENSTOCK, M. D., Fisch, G. S., et al. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000145371.23122.5a · Cited by 64
Self-citationKant, R., Chalansani, R., Chengappa, K. N. R., & Dieringer, M. F. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454604773840490 · Cited by 67
A novel de novo mutation inATP1A3and childhood-onset schizophrenia
Smedemark-Margulies, N., Brownstein, C. A., Vargas, S., Tembulkar, S. K., Towne, M. C., Shi, J., Gonzalez-Cuevas, E., Liu, K. X., Bilgüvar, K., Kleiman, R. J., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a001008 · Cited by 63
Clozapine-Induced Neutropenia in Children: Management with Lithium Carbonate
Sporn, A., Gogtay, N., Ortiz-Aguayo, R., Alfaro, C., Tossell, J., Lenane, M., Gochman, P., & Rapoport, J. L. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322572697 · Cited by 56
Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations
Stroup, T. S., Alves, W. M., Hamer, R. M., & Lieberman, J. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1956 · Cited by 62
Frick, P. J., & Silverthorn, P. (2002) · Springer eBooks · doi:10.1007/0-306-47377-1_31 · Cited by 68
de Pablo, G. S., Catalán, A., Vaquerizo‐Serrano, J., Pedruzo, B., Alameda, L., Sandroni, V., Armendariz, A., Rodríguez, V., Arango, C., Moreno, C., et al. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.203 · Cited by 64
Swadi, H. S., Craig, B. J., Pirwani, N. Z., Black, V., Buchan, J. C., & Bobier, C. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283320511 · Cited by 54
Tardive dyskinesia in children treated with atypical antipsychotic medications
Wonodi, I., Reeves, G. M., Carmichael, D. L., Verovsky, I., Avila, M. T., Elliott, A., Hong, L. E., Adami, H. M., & Thaker, G. K. (2007) · Movement Disorders · doi:10.1002/mds.21618 · Cited by 54
Rosenheck, R. A. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.1.85 · Cited by 66
Jensen, J. B., Kumra, S., Leitten, W., Oberstar, J. V., Anjum, A., White, T. J. H., Wozniak, J. R., Lee, S. S., & Schulz, S. C. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0123 · Cited by 56
Self-citationKumra, S., Jacobsen, L. K., Lenane, M., Smith, A. R., Lee, P. C., Malanga, C. J., Karp, B. I., HAMBURGER, S., & Rapoport, J. L. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00016 · Cited by 53
Self-citationHollis, C. P. (2000) · Advances in Psychiatric Treatment · doi:10.1192/apt.6.2.83 · Cited by 61
Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review
Pardis, P., Remington, G. J., Panda, R., Lemez, M., & Agid, O. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119862535 · Cited by 53
New generation antipsychotics for first episode schizophrenia
Hamann, J., Kissling, W., Leucht, S., & Rummel-Kluge, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004410 · Cited by 49
Couchman, L., Bowskill, S. V. J., Handley, S. A., Patel, M. X., & Flanagan, R. J. (2012) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2012.00374.x · Cited by 51
Corson, P. W., OʼLeary, D. S., Miller, D. D., & Andreasen, N. C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01421-x · Cited by 53
Differentiating Childhood-Onset Schizophrenia From Psychotic Mood Disorders
Calderoni, D., Wudarsky, M., Bhangoo, R. K., Dell, M. L., Nicolson, R., Hamburger, S. D., Gochman, P., Lenane, M., Rapoport, J. L., & Leibenluft, E. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200110000-00013 · Cited by 51
Off-Label Use of Clozapine in Children and Adolescents—A Literature Review
Rachamallu, V., Elberson, B. W., Vutam, E., & Aligeti, M. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000894 · Cited by 50
Antipsychotic medication for childhood-onset schizophrenia
Kennedy, E., Kumar, A., & Datta, S. S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004027.pub2 · Cited by 56
Grey matter and cognitive deficits in young relatives of schizophrenia patients
Bhojraj, T. S., Francis, A., Montrose, D. M., & Keshavan, M. S. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.069 · Cited by 52
Hormonal Correlates of Clozapine-Induced Weight Gain in Psychotic Children: An Exploratory Study
Sporn, A. L., Bobb, A. J., Gogtay, N., Stevens, H. E., GREENSTEIN, D. K., CLASEN, L. S., Tossell, J. W., Nugent, T. F., Gochman, P., Sharp, W. S., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000170552.15798.dd · Cited by 49
Prevalence of Atypical Antipsychotic Drug Use Among Commercially Insured Youths in the United States
Curtis, L. H., Masselink, L. E., Østbye, T., Hutchison, S., Dans, P. E., Wright, A., Krishnan, R. R., & Schulman, K. A. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.4.362 · Cited by 51
Tolerability Profile of Atypical Antipsychotics in Children and Adolescents
Stigler, K. A., Potenza, M. N., & McDougle, C. J. (2001) · Pediatric Drugs · doi:10.2165/00128072-200103120-00005 · Cited by 48
Pubertal development and onset of psychosis in childhood onset schizophrenia
Frazier, J. A., Alaghband‐Rad, J., Jacobsen, L. K., Lenane, M., Hamburger, S., Albus, K., Smith, A. K., McKenna, K., & Rapoport, J. L. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)03062-x · Cited by 47
Paediatric uses of atypical antipsychotics
Findling, R. L., McNamara, N. K., & Gracious, B. L. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.935 · Cited by 46
“We are aware of only one randomised clinical trial that compared the effectiveness of clozapine to a neuroleptic in juveniles with neuroleptic resistant schizophrenia [14].”
BackgroundRasimas, J. J., & Liebelt, E. L. (2012) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2012.09.005 · Cited by 48
Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update
Pillay, J., Boylan, K., Newton, A. S., Hartling, L., Vandermeer, B., Nuspl, M., MacGregor, T., Featherstone, R. M., & CARREY, N. J. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718779950 · Cited by 48
Ethical issues in psychopharmacology of children and adolescents
Kölch, M. G., Schnoor, K., & Fegert, J. M. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328314b776 · Cited by 50
Pediatric psychopharmacology: Too much or too little?
Rapoport, J. L. (2013) · World Psychiatry · doi:10.1002/wps.20028 · Cited by 44
Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care
Leo, R. J., & Regno, P. A. D. (2000) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v02n0601 · Cited by 46
Cerebral glucose metabolism in childhood onset schizophrenia
Jacobsen, L. K., Hamburger, S. D., Horn, J. D. V., Vaituzis, A. C., McKenna, K., Frazier, J. A., Gordon, C. T., Lenane, M., Rapoport, J. L., & Zametkin, A. J. (1997) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(97)00050-4 · Cited by 44
Zima, B. T., Bussing, R., Crecelius, G. M., Kaufman, A., & Belin, T. R. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.11.1732 · Cited by 48
Schizophrenia: Improving Outcome
Bustillo, J. R., Lauriello, J., & Keith, S. J. (1999) · Harvard Review of Psychiatry · doi:10.3109/10673229909000335 · Cited by 45
Child and adolescent schizophrenia: pharmacological approaches
Madaan, V., Dvir, Y., & Wilson, D. R. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.12.2053 · Cited by 45
Psychosis in children: diagnosis and treatment
Courvoisie, H. E., Labellarte, M. J., & Riddle, M. A. (2001) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2001.3.2/hcourvoisie · Cited by 45
Antipsychotics use in children and adolescents: An on-going challenge in clinical practice
Schneider, C., Taylor, D. M., Zalsman, G., Frangou, S., & Kyriakopoulos, M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114533599 · Cited by 41
Cerebellar development in childhood onset schizophrenia and non-psychotic siblings
GREENSTEIN, D. K., Lenroot, R., Clausen, L., Chavez, A. M., Ac, V., Tran, L., Gogtay, N., & Rapoport, J. L. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.02.010 · Cited by 43
Adnan, M., Motiwala, F., Trivedi, C. G., Sultana, T., Mansuri, Z., & Jain, S. B. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0092 · Cited by 41
Neurocognitive Outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study
Frazier, J. A., Giuliano, A. J., Johnson, J. L., Yakutis, L., Youngstrom, E. A., Breiger, D., Sikich, L., Findling, R. L., McClellan, J., Hamer, R. M., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.02.001 · Cited by 42
Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents
Calarge, C. A., Ivins, S. D., Motyl, K. J., Shibli-Rahhal, A. A., Bliziotes, M. M., & Schlechte, J. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313487548 · Cited by 41
Risperidone Monotherapy in Preschool Children With Pervasive Developmental Disorders
Masi, G., Cosenza, A., Mucci, M., & Vito, G. D. (2001) · Journal of Child Neurology · doi:10.1177/088307380101600602 · Cited by 39
Age-Grouped Differences in Adverse Drug Events from Psychotropic Medication
Safer, D. J. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0152 · Cited by 39
Psychopharmacology: Novel Antipsychotic Medications in the Treatment of Children and Adolescents
Malone, R. P., Sheikh, R. M., & ZITO, J. M. (1999) · Psychiatric Services · doi:10.1176/ps.50.2.171 · Cited by 39
Wohkittel, C., Gerlach, M., Taurines, R., Wewetzer, C., Unterecker, S., Burger, R., Schreck, D., Mehler‐Wex, C., Romanos, M., & Egberts, K. M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1573-y · Cited by 38
Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology
Blair, J., Taggart, B., & Martin, A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0153-8 · Cited by 39
Chalasani, L., Kant, R., & Chengappa, K. R. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104601010 · Cited by 37
Fell, M. J., Neill, J. C., Rao, C., & Marshall, K. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0131-3 · Cited by 38
Cobaugh, D. J., Erdman, A. R., Booze, L. L., Scharman, E. J., Christianson, G., Manoguerra, A. S., Caravati, E. M., Chyka, P. A., Woolf, A. D., Nelson, L. S., et al. (2007) · Clinical Toxicology · doi:10.1080/15563650701665142 · Cited by 35
Pharmacotherapy of Pervasive Developmental Disorders in Children and Adolescents
Masi, G. (2004) · CNS Drugs · doi:10.2165/00023210-200418140-00006 · Cited by 35
Ross, R. G., Heinlein, S., Zerbe, G. O., & Radant, A. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01437.x · Cited by 36
Antipsychotic drug toxicology in children
Caccia, S., Clavenna, A., & Bonati, M. R. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.562198 · Cited by 38
Strong Treatment Response and High Maintenance Rates of Clozapine in Childhood-Onset Schizophrenia
Kasoff, L. I., Ahn, K., Gochman, P., Broadnax, D. D., & Rapoport, J. L. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0103 · Cited by 34
15q13.3 duplication in two patients with childhood‐onset schizophrenia
Zhou, D., Gochman, P., Broadnax, D. D., Rapoport, J. L., & Ahn, K. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32439 · Cited by 36
Off-label use of antipsychotics: are we mad?
Haw, C., & Stubbs, J. H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.533 · Cited by 37
(2012) · The Malaysian journal of psychiatry · Cited by 33
Prescriber's Guide – Children and Adolescents: Stahl's Essential Psychopharmacology
Stahl, S. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108561402 · Cited by 35
Clinical effectiveness of new generation antipsychotics in adolescent patients
Arango, C., Parellada, M., & Moreno, D. M. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.08.006 · Cited by 33
Insomnia in Children: When are Hypnotics Indicated?
Younus, M., & Labellarte, M. J. (2002) · Pediatric Drugs · doi:10.2165/00128072-200204060-00006 · Cited by 36
Pediatric psychopharmacology: A review of new developments and recent research.
Brown, R. T., & Sammons, M. T. (2002) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.33.2.135 · Cited by 38
The antipsychotics. A pediatric perspective.
Findling, R., Schulz, S., Reed, M., & Blumer, J. (1998) · The Pediatric clinics of North America · doi:10.1016/s0031-3955(05)70070-5 · Cited by 32
Maher, K. N., Tan, M. P. J., Tossell, J. W., Weisinger, B., Gochman, P., Miller, R., GREENSTEIN, D. K., Overman, G. P., Rapoport, J. L., & Gogtay, N. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0136 · Cited by 32
Antipsychotics in children and adolescents with schizophrenia: A systematic review and meta-analysis
Grover, S., & Sarkar, S. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.117720 · Cited by 33
Treatment of Early Onset Schizophrenia: Recent Trends, Challenges and Future Considerations
Vyas, N. S., & Gogtay, N. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00029 · Cited by 34
Atypical Antipsychotic Use in a State Hospital Inpatient Adolescent Population
Kelly, D. L., Love, R. C., Mackowick, M., McMahon, R. P., & Conley, R. R. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454604773840517 · Cited by 32
Tiffin, P. A., & Welsh, P. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12136 · Cited by 31
Is There a Role for Clozapine in the Treatment of Children and Adolescents?
Findling, R. L., Frazier, J. A., Gerbino-Rosen, G., Kranzler, H. N., Kumra, S., & Kratochvil, C. J. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180ed94e · Cited by 30
Self-citationYalçın, Ö., Kaymak, G., Erdoğan, A., Tanıdır, C., Karaçetin, G., Kılıçoğlu, A. G., Mutlu, C., Adaletli, H., Güneş, H., Bahalı, K., et al. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0020 · Cited by 32
Kim, Y., Kim, B., Cho, S.-C., Kim, J., & Shin, M. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.982 · Cited by 29
Semantic processing and thought disorder in childhood-onset schizophrenia: Insights from fMRI
Piero, L. B. D., McNealy, K., Siddarth, P., Wu, K. N., Dapretto, M., & Caplan, R. (2009) · Journal of Neurolinguistics · doi:10.1016/j.jneuroling.2009.07.004 · Cited by 29
Glycopyrrolate for Treatment of Clozapine-Induced Sialorrhea in Three Adolescents
Robb, A. S., Lee, R. H., Cooper, E. B., Siedel, J. V., & Nusrat, N. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0037 · Cited by 28
Psychopharmacologic Treatment of Psychosis in Children and Adolescents
Kranzler, H. N., & Cohen, S. D. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.06.002 · Cited by 28
Conventional versus novel antipsychotics: changing concepts and clinical implications.
Remington, G. J., & Chong, S. A. (1999) · PubMed · Cited by 28
Review of antipsychotics in children and adolescents
Kapetanovic, S., & Simpson, G. M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.14.1871 · Cited by 33
Child and Adolescent Schizophrenia
Hollis, C. P., & Rapoport, J. L. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch3 · Cited by 30
Child and Adolescent Psychopharmacology Update
McVoy, M. K., & Findling, R. L. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.11.002 · Cited by 30
Clozapine prescribing in adolescent psychiatry: survey of prescribing practice in in-patient units
Cirulli, G. (2005) · Psychiatric Bulletin · doi:10.1192/pb.29.10.377 · Cited by 27
Including Children and Adolescents With Schizophrenia in Medication-Free Research
Kumra, S., Briguglio, C., Lenane, M., Goldhar, L., Bedwell, J. S., Venuchekov, J., Jacobsen, L. K., & Rapoport, J. L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1065 · Cited by 27
Self-citationMarkovic, A., Buckley, A. W., Driver, D. I., Broadnax, D. D., Gochman, P., Hoedlmoser, K., Rapoport, J. L., & Tarokh, L. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.08.022 · Cited by 27
Antipsychotic Medications for Children and Adolescents
Gracious, B., & Findling, R. L. (2001) · Pediatric Annals · doi:10.3928/0090-4481-20010301-07 · Cited by 26
Kranzler, H. N., Kester, H. M., Gerbino-Rosen, G., Henderson, I., Youngerman, J. K., Beauzile, G., Ditkowsky, K., & Kumra, S. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.008 · Cited by 27
Self-citationOlfson, M., Gerhard, T., Huang, C. Y., LIEBERMAN, J., Bobo, W. V., & Crystal, S. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq172 · Cited by 27
Remission Status and Cortical Thickness in Childhood-Onset Schizophrenia
GREENSTEIN, D. K., Wolfe, S., Gochman, P., Rapoport, J. L., & Gogtay, N. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181825b0c · Cited by 25
Metadata
- Authors
- Kumra, S.
- Affiliations
- National Institute of Mental Health (US)
- Corresponding author
- Kumra, Sanjiv
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1996-12-01
- Volume
- 53
- Issue
- 12
- Pages
- 1090
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2125778283
- Cited by
- 410
- References
- 53
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 3 · 2016: 13 · 2015: 5 · 2014: 7 · 2013: 19 · 2012: 23
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- childhood schizophrenia, clozapine, haloperidol, treatment-resistant schizophrenia, antipsychotic efficacy, adverse drug reactions, neutropenia, seizures, positive and negative symptoms, child psychiatry, atypical antipsychotics
- MeSH terms
- Adolescent, Age Factors, Child, Child, Preschool, Clozapine, Double-Blind Method, Drug Administration Schedule, Haloperidol, Humans, Neutropenia, Psychiatric Status Rating Scales, Schizophrenia, Childhood, Seizures, Severity of Illness Index, Treatment Outcome, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.